Development of a new subclavian arterial infusion chemotherapy method for locally or recurrent advanced breast cancer using an implanted catheter-port system after redistribution of arterial tumor supply.
Acute myeloid leukaemia.
Short NJ, Rytting ME, Cortes JE.
Lancet. 2018 Aug 18;392(10147):593-606. doi: 10.1016/S0140-6736(18)31041-9. Epub 2018 Aug 2.
A review of treatment options employed in relapsed/refractory AML.
Mohamed Jiffry MZ, Kloss R, Ahmed-Khan M, Carmona-Pires F, Okam N, Weeraddana P, Dharmaratna D, Dandwani M, Moin K.
Hematology. 2023 Dec;28(1):2196482. doi: 10.1080/16078454.2023.2196482.
Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease.
Burton C, Allen P, Herrera AF.
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433502. doi: 10.1200/EDBK_433502.
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD; Herceptin Adjuvant (HERA) Trial Study Team.
N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306.
PSMA PET imaging in the diagnosis and management of prostate cancer.
Houshmand S, Lawhn-Heath C, Behr S.
Abdom Radiol (NY). 2023 Dec;48(12):3610-3623. doi: 10.1007/s00261-023-04002-z. Epub 2023 Jul 26.
Anastrozole.
Cuzick J.
Drugs Today (Barc). 2005 Apr;41(4):227-39. doi: 10.1358/dot.2005.41.4.908563.
Developmental chemotherapy and management of recurrent ovarian cancer.
Bookman MA.
J Clin Oncol. 2003 May 15;21(10 Suppl):149s-167s. doi: 10.1200/jco.2003.02.553.
Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidine.
Mishima S, Kawazoe A, Shitara K.
Expert Opin Drug Saf. 2020 Sep;19(9):1063-1068. doi: 10.1080/14740338.2020.1805428. Epub 2020 Aug 12.
A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes.
O'Halloran N, Lowery A, Curran C, McLaughlin R, Malone C, Sweeney K, Keane M, Kerin M.
Clin Breast Cancer. 2019 Oct;19(5):377-382. doi: 10.1016/j.clbc.2019.04.011. Epub 2019 May 2.
Treatment of recurrent ovarian cancer with pegylated liposomal doxorubicin: a reappraisal and critical analysis.
Lorusso D, Sabatucci I, Maltese G, Lepori S, Tripodi E, Bogani G, Raspagliesi F.
Tumori. 2019 Aug;105(4):282-287. doi: 10.1177/0300891619839308. Epub 2019 Mar 28.
